(Q44628088)

4 December 2017

title

Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer (English)

1 reference

4 December 2017

1 reference

See W

1

1 reference

4 December 2017

Iversen P

2

1 reference

4 December 2017

Wirth M

3

1 reference

4 December 2017

McLeod D

4

1 reference

4 December 2017

Garside L

5

1 reference

4 December 2017

Morris T

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

44

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

512-7; discussion 517-8

1 reference

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

The bicalutamide Early Prostate Cancer Program. Demography

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

On the use and utility of the Weibull model in the analysis of survival data

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Pharmacodynamics and pharmacokinetics of bicalutamide: defining an active dosing regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Combined finasteride and flutamide therapy in men with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900366-X

7 January 2021

10.1016/S0302-2838(03)00366-X

Identifiers

DOI

1 reference

release_sdygqalwg5hotnqbywf5xq3otu

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sdygqalwg5hotnqbywf5xq3otu

24 November 2022

mapped directly with Wikidata item

1 reference